Telomir Pharmaceuticals, Inc.

TELO·NASDAQ·$1.29Share Price as of 11/2·$44MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/13/26 10-QQ1 ended 03/31/2605/14/26 10-KFY 202503/17/26 10-QQ3 ended 09/30/2511/10/25 10-QQ2 ended 06/30/2508/14/25

Disclosures

8-KCurrent report10/06/26 8-KCurrent report09/17/26 8-KCurrent report09/16/26 8-KCurrent report09/14/26 8-KCurrent report08/10/26

Prospectuses and Registrations

S-3Shelf registration10/27/26 S-3Shelf registration02/14/25 424B1Prospectus02/12/24 424B4Prospectus02/12/24 S-1/ARegistration statement (amended)01/03/24

Proxies

DEFA14AAdditional proxy materials08/19/26 DEF 14ADefinitive proxy07/28/26 DEFA14AAdditional proxy materials02/19/26 DEFM14ADefinitive proxy (merger)02/19/26 PRER14APreliminary proxy (revised)02/05/26

Ownership

SC 13G/ABeneficial ownership (amended)08/14/26 Form 4Insider transaction07/27/26 Form 4Insider transaction07/27/26 Form 4Insider transaction07/27/26 Form 3Initial insider ownership06/09/26

Other

EFFECTRequest for effectiveness02/28/25 CORRESPCorrespondence with the SEC02/26/25 UPLOADLetter from the SEC02/20/25 CERTCEO/CFO certification02/08/24 EFFECTRequest for effectiveness02/08/24